With this concept, among several kinds of transgenes are being investigated, both TRAIL; as a unique antitumor apoptosis inducing agent [17–19], and IL-12; as a powerful antitumor immunostimulatory cytokine [23–26], seemed to represent the most promising candidates in the theme of cancer gene therapy. Here, TNFSF10 is linked to cancer.